TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32683732

Group type: EXPERIMENTAL
Intervention: Relaxation therapy in addition to standard dermatology treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard dermatology treatment only (Control)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Relaxation therapy
Number of subjects: 60
Study: 33722518

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A treatment in addition to oral medication (B+ group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Oral medication only (B- group)
Number of subjects: 60
Study: 33481179

Group type: EXPERIMENTAL
Intervention: Oral magnesium sulfate 1 mL/kg/day for 1 month
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Oral magnesium sulfate
Number of subjects: 100
Study: 35429739

Group type: EXPERIMENTAL
Intervention: Immersive psychosocial training program and 10-min daily exercise (36 days total; n = 23; depressed at baseline n = 14)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Gratitude journaling control group (36 days total; n = 22; depressed at baseline n = 13)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Immersive psychosocial training program
Number of subjects: 45

Group type: COMPARATOR
Intervention: Gratitude journaling control group
Number of subjects: 45
Study: 33771952

Group type: EXPERIMENTAL
Intervention: Vergence/accommodative therapy
Number of subjects: 310

Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 310
Study: 36260859

Group type: EXPERIMENTAL
Intervention: mRNA-1273 vaccine (25-μg injections, two doses, administered 28 days apart)
Number of subjects: 4802

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4802

Group type: EXPERIMENTAL
Intervention: mRNA-1273 vaccine (25-μg injections, two doses)
Number of subjects: 4802
Study: 34767575

Group type: EXPERIMENTAL
Intervention: Blended cognitive-behavioural therapy (bCBT)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Face-to-face cognitive-behavioural therapy (ftfCBT)
Number of subjects: 114
Study: 33564849

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBOT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham conditions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo effects
Number of subjects: 0

Group type: COMPARATOR
Intervention: Heterogeneity in symptoms and treatments
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tangential medical issues
Number of subjects: 0
Study: 34231956

Group type: EXPERIMENTAL
Intervention: Conventional freehand dental implant placement
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Dynamic computer-aided implant surgery (CAIS)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Static computer-aided implant surgery (CAIS)
Number of subjects: 90

Group type: COMPARATOR
Intervention: All techniques (Conventional freehand, Dynamic CAIS, Static CAIS)
Number of subjects: 90
Study: 32184121

Group type: EXPERIMENTAL
Intervention: Cisplatin (CDDP) 40 mg/m2 plus radiation therapy (RT)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Cetuximab (CTX) 250 mg/m2 plus a loading dose of 400 mg/m2 plus radiation therapy (RT)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Cisplatin (CDDP) in HPV+ oropharyngeal carcinoma
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Cetuximab (CTX) in HPV- oropharyngeal carcinoma
Number of subjects: 70
Study: 35076737

Group type: EXPERIMENTAL
Intervention: Robotic-assisted laparoscopic fundoplication (RALF)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional laparoscopic fundoplication (CLF)
Number of subjects: 40
Study: 33000390

Group type: EXPERIMENTAL
Intervention: Computerized decision support alert for anticoagulation prescription
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Patients categorized as high-risk for bleeding
Number of subjects: 248
Study: 33715238

Group type: EXPERIMENTAL
Intervention: Behavioural Intervention (BI)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Chilled Water Station (CWS)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control (neither intervention)
Number of subjects: 61
Study: 34039236

Group type: EXPERIMENTAL
Intervention: My Food & Mood m‐Health program for 8 weeks
Number of subjects: 0
Study: 33061398

Group type: COMPARATOR
Intervention: Low-dose simvastatin (≤20 mg/day)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: High-dose atorvastatin (40 mg/day for 6 weeks, then 80 mg/day for 6 weeks)
Number of subjects: 125
Study: 35688116

Group type: EXPERIMENTAL
Intervention: Technology group (tablet use)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Comparison group (toys use)
Number of subjects: 70
Study: 34418221

Group type: EXPERIMENTAL
Intervention: Internet-based guided self-help (GSH) program
Number of subjects: 63

Group type: COMPARATOR
Intervention: Waitlist control group with positive expectation induction
Number of subjects: 63

Group type: COMPARATOR
Intervention: Waitlist control group without positive expectation induction
Number of subjects: 63
Study: 32179393

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided erector spinae plane block (ESPB) with 25 ml of 0.5% ropivacaine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal saline (Control group)
Number of subjects: 0
Study: 33395690

Group type: EXPERIMENTAL
Intervention: Environmental treatments with diverse microbial communities
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Environmental perturbations
Number of subjects: 12
Study: 34665507

Group type: EXPERIMENTAL
Intervention: micellar curcumin
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: curcumin-γ-cyclodextrin complex
Number of subjects: 12

Group type: COMPARATOR
Intervention: all other formulations
Number of subjects: 12
Study: 35320215

Group type: EXPERIMENTAL
Intervention: Sodium phosphate in zero-calorie soft drink (Group B)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Sodium phosphate in water (Group A)
Number of subjects: 162
Study: 32134129

Group type: EXPERIMENTAL
Intervention: Liberal transfusion strategy (RBC top-up transfusion to 12 g/dL)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Restrictive transfusion strategy (no RBCs)
Number of subjects: 67
Study: 33412339

Group type: EXPERIMENTAL
Intervention: Carnoy's solution applied for 5 minutes after surgical excision
Number of subjects: 40

Group type: COMPARATOR
Intervention: Surgical excision without Carnoy's solution
Number of subjects: 40
Study: 33314440

Group type: EXPERIMENTAL
Intervention: 1.5% NaOCl for 30 min
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 1.5% NaOCl for 60 min
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 1.5% NaOCl + PUI for 30 min
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 1.5% NaOCl + PUI for 60 min
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 5.25% NaOCl for 30 min
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 5.25% NaOCl for 60 min
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 5.25% NaOCl + PUI for 30 min
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 5.25% NaOCl + PUI for 60 min
Number of subjects: 60

Group type: COMPARATOR
Intervention: Distilled water for 30 min
Number of subjects: 60

Group type: COMPARATOR
Intervention: Distilled water for 60 min
Number of subjects: 60
Study: 35857811

Group type: EXPERIMENTAL
Intervention: Switchers (those who switched to the other antipsychotic)
Number of subjects: 327

Group type: COMPARATOR
Intervention: Stayers (those who remained on the same compound)
Number of subjects: 327
Study: 33617999

Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 395

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: Dermatological consultation
Number of subjects: 395

Group type: COMPARATOR
Intervention: No dermatological consultation
Number of subjects: 395
Study: 32539907

Group type: EXPERIMENTAL
Intervention: SDM-PLUS
Number of subjects: 161

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 161
Study: 35998768

Group type: EXPERIMENTAL
Intervention: Acupuncture (standardized protocol)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 160
Study: 32873964

Group type: EXPERIMENTAL
Intervention: Sex-specific genetic variants for testosterone
Number of subjects: 337199

Group type: EXPERIMENTAL
Intervention: Sex-specific variants as genetic instruments for Mendelian randomization
Number of subjects: 337199

Group type: EXPERIMENTAL
Intervention: Sex-specific polygenic risk score models for testosterone
Number of subjects: 337199
Study: 32441987

Group type: EXPERIMENTAL
Intervention: Behavioral nudge survey
Number of subjects: 182

Group type: COMPARATOR
Intervention: Standard informed consent
Number of subjects: 182
Study: 36001509

Group type: EXPERIMENTAL
Intervention: SA‐MI Training (tactile stimulation applied to the left or right wrist during MI tasks)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control-Group (pure MI tasks without tactile sensation assistance)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: SA‐MI Training
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control-Group
Number of subjects: 26
Study: 34488851

Group type: EXPERIMENTAL
Intervention: Participation in a registry for RCTs
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Concerns regarding data storage in a registry
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Factors influencing participation
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Involvement of GP in decision-making
Number of subjects: 87
Study: 35906015

Group type: EXPERIMENTAL
Intervention: Persuasive messages focusing on vaccine safety
Number of subjects: 5784

Group type: COMPARATOR
Intervention: Control message
Number of subjects: 5784

Group type: EXPERIMENTAL
Intervention: Negative attribute frames, risky choice frames, and priming descriptive norms messages
Number of subjects: 5784
Study: 33502090

Group type: EXPERIMENTAL
Intervention: Empagliflozin (10, 25 mg)
Number of subjects: 6959

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6959

Group type: EXPERIMENTAL
Intervention: Polyvascular disease with kidney dysfunction
Number of subjects: 6959
Study: 34060003

Group type: EXPERIMENTAL
Intervention: Lookware™ (video game-based digital therapeutic)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control video game
Number of subjects: 54
Study: 34948744

Group type: EXPERIMENTAL
Intervention: Neuromuscular training (NMT) warm-up, performed 2 to 3 times a week for 20 weeks.
Number of subjects: 1409

Group type: COMPARATOR
Intervention: High team adherence to NMT warm-up (n = 17 teams).
Number of subjects: 1409

Group type: EXPERIMENTAL
Intervention: Efficacy analysis of NMT warm-up (n = 7 teams).
Number of subjects: 1409
Study: 34260836

Group type: EXPERIMENTAL
Intervention: Ruxolitinib (10 mg twice daily)
Number of subjects: 329

Group type: COMPARATOR
Intervention: Control therapy (investigator's choice from 10 options)
Number of subjects: 329
Study: 32051317

Group type: EXPERIMENTAL
Intervention: Platelet rich plasma (PRP) injection
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo injection
Number of subjects: 240
Study: 36115392

Group type: EXPERIMENTAL
Intervention: modified Blalock Taussig Thomas shunt (mBTTS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: right‐ventricular‐to‐pulmonary‐artery shunt (RVPAS)
Number of subjects: 0
Study: 36350712

Group type: EXPERIMENTAL
Intervention: Specialist palliative care intervention (four protocolized quarterly visits with a PC nurse practitioner)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 50
Study: 33782244

Group type: EXPERIMENTAL
Intervention: Digital nerve block (DNB) performed on the second and third PIPs of the dominant hand
Number of subjects: 83

Group type: COMPARATOR
Intervention: Control group (saline injection in the same level at the control side)
Number of subjects: 83
Study: 34843323

Group type: EXPERIMENTAL
Intervention: GenerationPMTO intervention
Number of subjects: 153
Study: 33857943

Group type: EXPERIMENTAL
Intervention: Individualized Homeopathy (IH)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 33244149

Group type: EXPERIMENTAL
Intervention: Placebo-Control Reminder Script (PCRS)
Number of subjects: 137

Group type: COMPARATOR
Intervention: No PCRS (Control)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Placebo (both groups)
Number of subjects: 137
Study: 36050695

Group type: EXPERIMENTAL
Intervention: 4 g/day Eicosapentaenoic acid (EPA) and Docosahexaenoic acid (DHA)
Number of subjects: 44

Group type: COMPARATOR
Intervention: 4 g/day olive oil (placebo)
Number of subjects: 44
Study: 33386187

Group type: EXPERIMENTAL
Intervention: Shared decision-making intervention
Number of subjects: 265

Group type: COMPARATOR
Intervention: Standard consent (Control)
Number of subjects: 265
Study: 36087395

Group type: EXPERIMENTAL
Intervention: Lanreotide autogel 120 mg (LAN)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 53
Study: 33978350

Group type: EXPERIMENTAL
Intervention: LDA + L-Arg (3g) + Mg (350 mg) + Sal (100 mg)
Number of subjects: 79

Group type: COMPARATOR
Intervention: LDA
Number of subjects: 79
Study: 35512154

Group type: EXPERIMENTAL
Intervention: Handheld image-free robotic system (robot group)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Conventional TKA (conventional group)
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 147
Study: 32911433

Group type: EXPERIMENTAL
Intervention: Early venoarterial extracorporeal membrane oxygenation–facilitated resuscitation for circulatory support and percutaneous coronary intervention, when needed.
Number of subjects: 174

Group type: COMPARATOR
Intervention: Standard advanced cardiac life support resuscitation.
Number of subjects: 174
Study: 35586025

Group type: EXPERIMENTAL
Intervention: MedSafer intervention (personalized deprescribing reports)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Usual care (medication reconciliation)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: MedSafer intervention
Number of subjects: 140

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 140
Study: 33262253

Group type: EXPERIMENTAL
Intervention: Real taVNS
Number of subjects: 70

Group type: COMPARATOR
Intervention: Sham taVNS
Number of subjects: 70
Study: 34244279

Group type: EXPERIMENTAL
Intervention: Light therapy (LT) delivered via a portable device, daily for 30 min at medium intensity for 8 weeks
Number of subjects: 50
Study: 36154518

Group type: EXPERIMENTAL
Intervention: Bright White Light (BWL) therapy at 10,000 lux, applied daily between the second and eighth days of chemotherapy
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (no BWL therapy)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Bright White Light (BWL) therapy
Number of subjects: 72
Study: 33916497

Group type: EXPERIMENTAL
Intervention: Clinically indicated peripheral intravenous replacement (CIPIR)
Number of subjects: 283

Group type: COMPARATOR
Intervention: Usual care with routine PVC replacement every three days (Control)
Number of subjects: 283
Study: 33951362

Group type: EXPERIMENTAL
Intervention: Dexamethasone (8 mg intravenous)
Number of subjects: 8880

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8880
Study: 34427681

Group type: EXPERIMENTAL
Intervention: Lung cancer screening with low-dose computed tomography (LDCT)
Number of subjects: 53452

Group type: COMPARATOR
Intervention: Chest radiograph screening
Number of subjects: 53452
Study: 32439422

Group type: EXPERIMENTAL
Intervention: Blended learning training programme
Number of subjects: 29
Study: 35743349

Group type: EXPERIMENTAL
Intervention: Conventional resin sealant
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Nanofilled resin sealant
Number of subjects: 62
Study: 36130174

Group type: EXPERIMENTAL
Intervention: Group-based cognitive-behavioral stress management intervention
Number of subjects: 102
Study: 33232588

Group type: EXPERIMENTAL
Intervention: Convalescent plasma
Number of subjects: 333

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 333
Study: 32745092

Group type: EXPERIMENTAL
Intervention: Aspirin 81-mg twice daily
Number of subjects: 329

Group type: COMPARATOR
Intervention: Low-molecular-weight heparin (LMWH) enoxaparin 30-mg twice daily
Number of subjects: 329

Group type: COMPARATOR
Intervention: Low-molecular-weight heparin (LMWH)
Number of subjects: 329
Study: 36351943

Group type: EXPERIMENTAL
Intervention: Device method
Number of subjects: 28

Group type: COMPARATOR
Intervention: Manual method
Number of subjects: 28
Study: 33938709

Group type: EXPERIMENTAL
Intervention: Intralesional Vitamin D3 injection
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intralesional Candida Albicans Antigen injection
Number of subjects: 40
Study: 32475159

Group type: EXPERIMENTAL
Intervention: COMPASS‐TC
Number of subjects: 6024

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 6024
Study: 34257407

Group type: EXPERIMENTAL
Intervention: Primeiros Laços (intervention group, n=40)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Healthcare as usual (control group, n=40)
Number of subjects: 80
Study: 33170239

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (2000 IU/d)
Number of subjects: 2157

Group type: EXPERIMENTAL
Intervention: Omega-3s (1 g/d)
Number of subjects: 2157

Group type: EXPERIMENTAL
Intervention: Strength-training exercise program
Number of subjects: 2157

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2157
Study: 36070045

Group type: EXPERIMENTAL
Intervention: At Home/Chez Soi dataset
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Without A Home dataset
Number of subjects: 2
Study: 33860587

Group type: EXPERIMENTAL
Intervention: Propolis plus Hyoscyamus niger L. methanolic extract syrup (1.6 mg of extract and 450 mg of propolis per 10 mL, administered three times a day for 6 days)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo syrup
Number of subjects: 50
Study: 32279123

Group type: EXPERIMENTAL
Intervention: Stroboscopic visual training (SVT)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control training (similar exercises without lenses)
Number of subjects: 26
Study: 35996188

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupoint stimulation (TEAS)
Number of subjects: 739

Group type: COMPARATOR
Intervention: No TEAS treatment (Control)
Number of subjects: 739
Study: 33506373

Group type: EXPERIMENTAL
Intervention: Intensive toilet training program
Number of subjects: 4
Study: 34061314

Group type: EXPERIMENTAL
Intervention: Centhaquine (0.01 mg/kg) administered in 100 mL of normal saline infusion over 1 h
Number of subjects: 105

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 105
Study: 32965539

Group type: EXPERIMENTAL
Intervention: 1-day ART (ART-123: day 1, placebo: days 2–3)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: 3-day ART (ART-123: days 1–3)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo (days 1–3)
Number of subjects: 79
Study: 34788569

Group type: EXPERIMENTAL
Intervention: UC + 12-week program of exercise and education (PREVENT)
Number of subjects: 184

Group type: COMPARATOR
Intervention: UC
Number of subjects: 184
Study: 34314400

Group type: EXPERIMENTAL
Intervention: Volar plate fixation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Plaster cast immobilization
Number of subjects: 0
Study: 35809289

Group type: EXPERIMENTAL
Intervention: Post-abortion care (PAC)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (no PAC)
Number of subjects: 72
Study: 32508141

Group type: EXPERIMENTAL
Intervention: Contingency information (yes)
Number of subjects: 467

Group type: EXPERIMENTAL
Intervention: Fear appeal (yes)
Number of subjects: 467

Group type: EXPERIMENTAL
Intervention: Combination of contingency information and fear appeal
Number of subjects: 467

Group type: COMPARATOR
Intervention: Control condition (irrelevant information)
Number of subjects: 467
Study: 37853408

Group type: COMPARATOR
Intervention: SMC + Vitamin A + PlumpyDoz (SMC-APd)
Number of subjects: 1059

Group type: COMPARATOR
Intervention: SMC + Vitamin A + Zinc (SMC-AZc)
Number of subjects: 1059

Group type: COMPARATOR
Intervention: Control
Number of subjects: 1059
Study: 33404689

Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 571
Study: 32084035

Group type: EXPERIMENTAL
Intervention: Exoskeleton-assisted walking
Number of subjects: 9

Group type: COMPARATOR
Intervention: Unassisted overground walking
Number of subjects: 9
Study: 34224785

Group type: EXPERIMENTAL
Intervention: Amino acid-based formula with synbiotics (AAF-S)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Amino acid-based formula (AAF)
Number of subjects: 169
Study: 34034748

Group type: EXPERIMENTAL
Intervention: Postprandial triglyceride (PTG) concentration during oral fat tolerance testing (OFTT)
Number of subjects: 472

Group type: COMPARATOR
Intervention: Healthy participants
Number of subjects: 472
Study: 33380521

Group type: EXPERIMENTAL
Intervention: Filgotinib
Number of subjects: 9

Group type: COMPARATOR
Intervention: Lanraplenib
Number of subjects: 9
Study: 36326664

Group type: EXPERIMENTAL
Intervention: Treatment Foster Care Oregon (TFCO)
Number of subjects: 166
Study: 33175627

Group type: EXPERIMENTAL
Intervention: Neutralised oxidised regenerated cellulose (NORC)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Oxidised regenerated cellulose (ORC)
Number of subjects: 236
Study: 33962041

Group type: EXPERIMENTAL
Intervention: Tenofovir alafenamide (TAF), n = 87
Number of subjects: 174

Group type: COMPARATOR
Intervention: Tenofovir disoproxil fumarate (TDF), n = 87
Number of subjects: 174
Study: 35710235

Group type: EXPERIMENTAL
Intervention: Tailored exercise and manual therapy
Number of subjects: 28

Group type: COMPARATOR
Intervention: Standardised exercise
Number of subjects: 28
Study: 35394821

Group type: EXPERIMENTAL
Intervention: SGLT2 inhibitors
Number of subjects: 49875
Study: 33259688

Group type: EXPERIMENTAL
Intervention: Lactobacillus brevis CD2 (4 billion colony‐forming units after breakfast, lunch, and dinner for 21 days)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Lactobacillus brevis CD2
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: COMPARATOR
Intervention: Lactobacillus brevis CD2 and Placebo
Number of subjects: 20
Study: 32187150

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Concurrent Training (CT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nutritional Guidance (NG)
Number of subjects: 0